Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person5
Longeveron Inc.
Company
ITRON, INC.
Company
Tron Inc.
Company
Londonla Inc.
Company
Evergy, Inc.
Company
Primary record20
INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A
0001104659-26-123523.txt : 20261105 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001319244 XXXXXXXX LIVE 1 Class A Common Stock, par value $0.001 per share 09/30/2026 0001721484 Longeveron Inc. 54303L302 1951 N
Longeveron Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On November 1, 2026, Ms. Ursula Ungaro provided Longeveron
Longeveron Inc. filed 8-K
Item 8.01. Other Events. On October 26, 2026, Longeveron Inc. (the “Company”) a clinical-stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions
Longeveron Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On October 7, 2026, Dr. Nataliya Agafonova informed manage
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-10-05.
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-10-05.
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-10-05.
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-10-05.
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-10-05.
Longeveron Inc. filed 8-K
Item 8.01. Other Events. On September 16, 2026, Longeveron Inc. (the Company ) a clinical-stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related condition
Longeveron Inc. filed 8-K
Item 8.01. Other Events. As previously disclosed, on September 22, 2025, Longeveron Inc. (the Company ) received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market ( Nasdaq ) advising that the Comp
Longeveron Inc. filed SCHEDULE 13G
0000935836-26-000483.txt : 20260910 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0001792126 XXXXXXXX LIVE Class A Common Stock 09/02/2026 0001721484 Longeveron Inc. 54303L302 1951 NW 7TH AVENUE, SUITE 520 MIAMI FL 3
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-08-25.
Longeveron Inc. filed 8-K
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On July 1, 2026 the stockholders of Longeveron Inc. (the Company ) approved a proposal at the Company s annual meeting of stockholders (
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-08-21.
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-08-21.
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-08-21.
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-08-21.
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-08-21.
Longeveron Inc. filed 4
SEC form 4 filed by Longeveron Inc. (CIK 1721484) on 2026-08-21.